Ohio State University’s MBE Research Team Developing IR Devices to Serve a Range of Consumer, Automotive, Defense, and Industrial Applications.
Veeco Instruments Inc. announced that it has received an order from the Ohio State University for its GENxcel® R&D Molecular Beam Epitaxy (MBE) System. The GENxcel system will be used for epitaxial growth of high-quality gallium-antimonide (GaSb) compound semiconductors for infrared detectors (IR), The system, winner of the 2018 Compound Semiconductor (CS) Industry Innovation Award, will be delivered to the Ohio State University’s Krishna Infrared Detectors Laboratory.
“We are excited to partner with Veeco to add new MBE research capabilities with the acquisition of the GENxcel system,” commented Professor Sanjay Krishna, who leads the Krishna Infrared Detector (KIND) Laboratory at Ohio State University. “This will enable us to grow high-quality antimonide semiconductor material to explore novel device physics and train the next generation of students with advanced semiconductor skills.”
According to a MarketsandMarkets™ report, the size of the infrared detector market is predicted to grow from $535 million starting in 2023 to $731 million by 2028, resulting in a 7 percent compound annual growth rate. The report states the IR market is driven by increasing demand for security and surveillance systems, adoption of IR devices in industrial automation and manufacturing processes, and high penetration of IR devices in non-contact temperature measurement, gas analysis, astronomy, and fire detection applications.
“We are honored to have been selected by Dr. Krishna and his research team at Ohio State University,” commented Matthew Marek, Senior Director of Marketing for Veeco’s MBE Group. “Dr. Krishna’s deep expertise in this field promises to advance the industry’s understanding of these materials, paving the way for new technological developments. Partnering with such a distinguished researcher enhances our commitment to driving impactful material science innovations. We look forward to continued collaboration with Dr. Krishna and his team.”
